Cover Image


View/Hide Left Panel

Redon, R., Ishikawa, S., Fitch, K.R., Feuk, L., Perry, G.H., Andrews, T.D., Fiegler, H., Shapero, M.H., Carson, A.R., Chen, W., Cho, E.K., Dallaire, S., Freeman, J.L., González, J.R., Gratacòs, M., Huang, J., Kalaitzopoulos, D., Komura, D., MacDonald, J.R., Marshall, C.R., Mei, R., Montgomery, L., Nishimura, K., Okamura, K., Shen, F., Somerville, M.J., Tchinda, J., Valsesia, A., Woodwark, C., Yang, F., Zhang, J., Zerjal, T., Zhang, J., Armengol, L., Conrad, D.F., Estivill, X., Tyler-Smith, C., Carter, N.P., Aburatani, H., Lee, C., Jones, K.W., Scherer, S.W., and Hurles, M.E. (2006). Global variation in copy number in the human genome. Nature, 444, 444-454.

Reinwald, S., and Weaver, C.M. (2006). Soy isoflavones and bone health: A double-edged sword? Journal of Natural Products, 69(3), 450-459.

Ross, S.A. (2003). Diet and DNA methylation interactions in cancer prevention. Annals of the New York Academy of Sciences, 983, 197-207.

Schatzkin, A., and Gail, M. (2002). The promise and peril of surrogate end points in cancer research. Nature Reviews Genetics, 2, 1-9.

Scheuner, M.T. (2001). Genetic predisposition to coronary artery disease. Current Opinion in Cardiology, 16(4), 251-260.

Singer, P.A., and Daar, D.A. (2001). Harnessing genomics and biotechnology to improve global health equity. Science, 294, 87-89.

Slattery, M.L., Neuahusen, S.L., Hoffman, M., Caan, B., Curtin, K., Ma, K.N., and Samowitz W. (2004). Dietary calcium, vitamin D, VDR genotypes, and colorectal cancer. International Journal of Cancer, 111, 750-756.

Stover, P. (2006). Influence of human genetic variation on nutritional requirements. American Journal of Nutrition, 83(Suppl.), 436S-442S.

Thomas, J.C., Irwin, D.E., Shaugnessy Zuiker, E., and Millikan, R.C. (2005). Genomics and the public health code of ethics. American Journal of Public Health, 95(12), 2139-2143.

Thomas, T., Gallo, M.A., and Thomas, T.J. (2004). Estrogen receptors as targets for drug development for breast cancer, osteoporosis, and cardiovascular diseases. Current Cancer Drug Targets, 4(6), 483-499.

Trujillo, E., Davis, C., and Milner, J. (2006). Nutrigenomics, proteomics, metabolomics, and the practice of dietetics. Journal of the American Dietetic Association, 106, 403-413.

Uusitupa, M.I., Ruuskanen, E., Makinen, E., Laitinen, J., Toskala, E., Kervinen, K., and Kesaniemi, Y.A. (1992). A controlled study on the effect of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: Relation to apolipoprotein E phenotype. Journal of the American College of Nutrition, 11(6), 651-659.

van Erk, M.J., Blom, W.A.M., van Ommen, B., and Hendriks, H.F.J. (2006). High-protein and high-carbohydrate breakfasts differentially change the transcriptome of human blood cells. American Journal of Clinical Nutrition, 84, 1233-1241.

Viguerie, N., Poitou, C., Cancello, R., Stich, V., Clement, K., and Langin, D. (2005, January). Transcriptomics applied to obesity and caloric restriction. La biochimie, 87(1), 117-123.

Warren, A.J., and Shields, P.G. (1997). Molecular epidemiology: Carcinogen-DNA adducts and genetic susceptibility. Proceedings of the Society for Experimental Biology and Medicine, 216, 172-180.

Way, T.D., Kao, M.C., and Lin, J.K. (2004). Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway. Journal of Biological Chemistry, 279(6), 4479-4489.

Wiedmann, M.W., and Caca, K. (2005). Molecularly targeted therapy for gastrointestinal cancer. Current Cancer Drug Targets, 5(3), 171-193.

Wong, H.L., Seow, A., Arakawa, K., Lee, H.P., Yu, M.C., and Ingles, S.A. (2003). Vitamin DVitamin D receptor start codon polymorphism and colorectal cancer risk: Effect modification by dietary calcium and fat in Singapore Chinese. Carcinogenesis, 24, 1091-1095.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement